Judy George

Familial genetic factors, confounding may have driven previous outcomes

Nex-z trials aim to treat transthyretin amyloidosis with cardiomyopathy or polyneuropathy

News and commentary from the world of neurology and neuroscience

Survival rates varied considerably by clinical type of disease

Claseprubart demonstrates safety in phase II trial

Glymphatic system markers predicted dementia over 5 years

News and commentary from the world of neurology and neuroscience

Aneurysms may be more common than you think

Study links periodontal disease with cerebral small vessel disease, stroke

Prolonged Gabapentin Use for Pain After Stroke Sparks Questions About Risks

Starting treatment early in hospice tied to shorter survival for patients not imminently dying

Korean study echoes previous claims, but relationship remains inconclusive

Drug didn't meet efficacy threshold and doubled serious adverse event risk, analysis suggests

News and commentary from the world of neurology and neuroscience

If there's talk of an autism epidemic, 'the immediate question must be, which kind of autism?'

Despite EPA ban, thousands of sites remain contaminated with trichloroethylene

Minimizing pregnancy-related relapses remains critical

Outcomes suggest being active may have neuroprotective benefits

Trends favored vidofludimus calcium on disability progression

Evidence supporting the drug's use in autism patients is limited